Skip header and navigation
CMA PolicyBase

Policies that advocate for the medical profession and Canadians


14 records – page 1 of 2.

Acquired immunodeficiency syndrome (Update 2000)

https://policybase.cma.ca/en/permalink/policy165
Last Reviewed
2020-02-29
Date
2000-12-09
Topics
Health care and patient safety
  1 document  
Policy Type
Policy document
Last Reviewed
2020-02-29
Date
2000-12-09
Replaces
Acquired immunodeficiency syndrome (1989)
Topics
Health care and patient safety
Text
Acquired immunodeficiency syndrome (UPDATE 2000) The Canadian Medical Association has developed the following general principles to serve as guidelines for various bodies, health care professionals and the general public. Specific aspects of infection with human immunodeficiency virus (HIV) and acquired immunodeficency syndrome (AIDS) that relate to physicians' ethical responsibilities as well as society's moral obligations are discussed. Such matters include: the need for education, research and treatment resources; the patient's right to investigation and treatment and to refuse either; the need to obtain the patient's informed consent; the right to privacy and confidentiality; the importance of infection control; and the right to financial compensation in the case of occupational exposure to HIV. Education Physicians should keep their knowledge of AIDS and HIV infection up to date. Physicians should educate patients and the general public in the prevention of AIDS by informing them of means available to protect against the risk of HIV infection and to avoid further transmission of the virus. Health authorities should maintain an active public education program on AIDS that includes the school population and such initiatives as public service announcements by the media. Resources All levels of government should provide resources for adequate information and education of health care professionals and the public on HIV-related diseases; research into the prevention and treatment of HIV infection and AIDS; and the availability and accessibility of proper diagnosis and care for all patients with HIV infection. HIV antibody testing Physicians have an ethical responsibility to recommend appropriate testing for HIV antibody and to care for their patients with AIDS or refer them to where treatment is available. Physicians should provide counselling to patients before and after HIV antibody testing. Because of the potential psychologic, social and economic consequences attached to a positive HIV test result, informed consent must, with rare exceptions, be obtained from a patient before testing. However, the CMA endorses informed mandatory testing for HIV infection in cases involving the donation of blood, body fluids or organs. The CMA recognizes that people who have doubts about their serologic status may avoid being tested for fear of indiscretion and therefore supports voluntary non-nominal testing of potential HIV carriers on request. The CMA supports the Canadian Blood Service and Hema-Québec in their programs of testing and screening blood donations and blood products. Confidentiality in reporting and contact tracing The CMA supports the position that cases of HIV infection should be reported non-nominally with enough information to be epidemiologically useful. In addition, each confirmed case of AIDS should be reported non-nominally to a designated authority for epidemiologic purposes. The CMA encourages attending physicians to assist public health authorities to trace and counsel confidentially all contacts of patients with HIV infection. Contact tracing should be carried out with the cooperation and participation of the patient to provide maximum flexibility and effectiveness in alerting and counselling as many potentially infected people as possible. In some jurisdictions physicians may be compelled to provide detailed information to public health authorities. In such circumstances, the CMA urges those involved to maintain confidentiality to the greatest extent possible and to take all reasonable steps to inform the patient that their information is being disclosed. The CMA Code of Ethics (article 22) advises physicians that disclosure of a patient’s HIV status to a spouse or current sexual partner may not be unethical and, indeed, may be indicated when physicians are confronted with an HIV-infected patient who is unwilling to inform the person at risk. Such disclosure may be justified when all of the following conditions are met: the partner is at risk of infection with HIV and has no other reasonable means of knowing of the risk; the patient has refused to inform his or her sexual partner; the patient has refused an offer of assistance by the physician to do so on the patient's behalf; and the physician has informed the patient of his or her intention to disclose the information to the partner. The CMA stresses the need to respect the confidentiality of patients with HIV infection and consequently recommends that legal and regulatory safeguards to protect such confidentiality be established and maintained. Infection control Health care institutions and professionals should ensure that adequate infection-control measures in the handling of blood and body fluids are in place and that the rights of professionals directly involved in patient care to be informed of and protected from the risks of HIV infection are safeguarded. The CMA does not recommend routine testing of hospitalized patients. The CMA urges appropriate funding agencies to assess the explicit and implicit costs of infection control measures and to ensure that additional funds are provided to cover these extraordinary costs. Occupational exposure and the health care professional Health care workers should receive adequate financial compensation in the case of HIV infection acquired as a result of accidental occupational exposure. Physicians and other health care providers with HIV infection have the same rights as others to be protected from wrongful discrimination in the workplace and to be eligible for financial compensation for work-related infection. Physicians with HIV infection should consult appropriate colleagues to determine the nature and extent of the risk related to their continued involvement in the care of patients.
Documents
Less detail

International commercial surrogacy

https://policybase.cma.ca/en/permalink/policy13702
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-05
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-05
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Text
The Canadian Medical Association supports advocacy efforts to increase awareness of the physical and mental health risks associated with international commercial surrogacy.
Less detail

Opioid overdose prevention supplies available in publicly accessible locations

https://policybase.cma.ca/en/permalink/policy13703
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-06
The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-06
The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Text
The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Less detail

Cultural awareness

https://policybase.cma.ca/en/permalink/policy13704
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-16
The Canadian Medical Association encourages medical licensing bodies to require registrants to have training in cultural awareness.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-16
The Canadian Medical Association encourages medical licensing bodies to require registrants to have training in cultural awareness.
Text
The Canadian Medical Association encourages medical licensing bodies to require registrants to have training in cultural awareness.
Less detail

Nutritional guidelines in Canadian schools

https://policybase.cma.ca/en/permalink/policy13706
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-08
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Population health/ health equity/ public health
Resolution
GC17-08
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Text
The Canadian Medical Association supports mandatory adherence to national or province/territoryspecific nutritional guidelines in Canadian schools, including a means to monitor and report school compliance.
Less detail

Federal Genetic Non-Discrimination Act

https://policybase.cma.ca/en/permalink/policy13707
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-09
The Canadian Medical Association urges provincial and territorial governments to support the Federal Genetic Non-Discrimination Act (Bill S-201) by enacting corresponding legislation that echoes privacy protection.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-09
The Canadian Medical Association urges provincial and territorial governments to support the Federal Genetic Non-Discrimination Act (Bill S-201) by enacting corresponding legislation that echoes privacy protection.
Text
The Canadian Medical Association urges provincial and territorial governments to support the Federal Genetic Non-Discrimination Act (Bill S-201) by enacting corresponding legislation that echoes privacy protection.
Less detail

Victims of human trafficking

https://policybase.cma.ca/en/permalink/policy13708
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-17
The Canadian Medical Association supports increased physician awareness and education in identifying and supporting victims of human trafficking.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Ethics and medical professionalism
Health care and patient safety
Resolution
GC17-17
The Canadian Medical Association supports increased physician awareness and education in identifying and supporting victims of human trafficking.
Text
The Canadian Medical Association supports increased physician awareness and education in identifying and supporting victims of human trafficking.
Less detail

Federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks

https://policybase.cma.ca/en/permalink/policy13709
Date
2017-08-23
Topics
Health care and patient safety
Resolution
GC17-10
The Canadian Medical Association calls on the federal government to implement a federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks sold in Canada to subsidize healthier food options.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Resolution
GC17-10
The Canadian Medical Association calls on the federal government to implement a federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks sold in Canada to subsidize healthier food options.
Text
The Canadian Medical Association calls on the federal government to implement a federal excise tax on sugar-sweetened beverages and artificially-sweetened drinks sold in Canada to subsidize healthier food options.
Less detail

Antimicrobial stewardship and antimicrobial resistance surveillance

https://policybase.cma.ca/en/permalink/policy13710
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-11
The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Health care and patient safety
Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
Resolution
GC17-11
The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
Text
The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
Less detail

Mandatory labelling, warnings and a recall system for prescription pharmaceuticals

https://policybase.cma.ca/en/permalink/policy13714
Date
2017-08-23
Topics
Population health/ health equity/ public health
Health care and patient safety
Resolution
GC17-24
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Policy Type
Policy resolution
Date
2017-08-23
Topics
Population health/ health equity/ public health
Health care and patient safety
Resolution
GC17-24
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Text
The Canadian Medical Association calls for mandatory labelling, warnings and a recall system for prescription pharmaceuticals sold in Canada that contain gluten and/or priority allergens.
Less detail

14 records – page 1 of 2.